Breaking the barriers: Overcoming cancer resistance by targeting the NLRP3 inflammasome.
Pazhouhesh Far N, Hajiheidari Varnousafaderani M, Faghihkhorasani F, Etemad S, Abdulwahid ARR, Bakhtiarinia N, Mousaei A, Dortaj E, Karimi S, Ebrahimi N, Aref AR.
Pazhouhesh Far N, et al. Among authors: karimi s.
Br J Pharmacol. 2024 Oct 12. doi: 10.1111/bph.17352. Online ahead of print.
Br J Pharmacol. 2024.
PMID: 39394867
Review.